IDH2 and central nervous system cancer: Concerning the spectrum of IDH-mutant gliomas, diagnosis of an IDH-mutant astrocytoma requires histopathological findings consistent with an infiltrating diffuse glioma with an IDH1/IDH2 mutation and ATRX loss/mutation or exclusion of 1p/19q codeletion.